InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: None

Friday, 11/29/2019 7:33:28 AM

Friday, November 29, 2019 7:33:28 AM

Post# of 424415
report back from Jefferies call with Patent Lawyer

From dough
@semodough on twitter


$AMRN Key Takeaways from Call w/ Patent Lawyer + Preview of Upcoming Competitor Data-came away (+), with many of generic claims already abandoned or invalidated by court&view of settlement as probable or a high ~85% likelihood AMRN could win outright,potentially pushing it $25-30


expert $AMRN would likely win case outright (high probability, in his view) as many of generics' claims have been weakened Our DCF suggests stock is worth $30 on peak sales of $3-4B, every $1B higher peak flows to bottom line is worth $5/sh upside.



JEFF $AMRN Monday (11/25) at 1pm ET, we will be hosting a conference call with patent lawyer Jacob Sherkow to discuss the ongoing Vascepa patent litigation with Dr. Reddy and Hikma. We will discuss the recently published summary judgment and scenarios for upcoming litigation
9:38 PM · Nov 28, 2019·Twitter for iPhone
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News